Fidelity Disruptive Medicine ETF (FMED)
NASDAQ: FMED · Real-Time Price · USD
31.41
+0.41 (1.32%)
Sep 14, 2026, 4:00 PM EDT - Market closed
FMED Holdings Information
FMED is an equity ETF with a total of 78 individual holdings. The top holdings are Fidelity Securities Lending Cash Central Fund stock at 7.11%, 10x Genomics at 5.85%, Thermo Fisher Scientific at 3.89%, Natera at 3.67%, and Danaher at 3.59%.
Total Holdings
78
Top 10 Percentage
38.68%
Asset Class
Equity
ETF Category
Health
Assets
50.22M
PE Ratio
39.71
Breakdown by Country
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | n/a | Fidelity Securities Lending Cash Central Fund | 7.11% |
| 2 | TXG | 10x Genomics, Inc. | 5.85% |
| 3 | TMO | Thermo Fisher Scientific Inc. | 3.89% |
| 4 | NTRA | Natera, Inc. | 3.67% |
| 5 | DHR | Danaher Corporation | 3.59% |
| 6 | LFST | LifeStance Health Group, Inc. | 3.23% |
| 7 | ARGX | argenx SE | 3.14% |
| 8 | RVMD | Revolution Medicines, Inc. | 2.92% |
| 9 | ILMN | Illumina, Inc. | 2.80% |
| 10 | EPA: DIM | Sartorius Stedim Biotech S.A. | 2.50% |
| 11 | HTFL | HeartFlow, Inc. | 2.48% |
| 12 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.48% |
| 13 | COGT | Cogent Biosciences, Inc. | 2.26% |
| 14 | MRNA | Moderna, Inc. | 2.15% |
| 15 | ISRG | Intuitive Surgical, Inc. | 2.06% |
| 16 | ASND | Ascendis Pharma A/S | 2.03% |
| 17 | INSM | Insmed Incorporated | 2.00% |
| 18 | KYMR | Kymera Therapeutics, Inc. | 1.95% |
| 19 | PCVX | Vaxcyte, Inc. | 1.84% |
| 20 | KNSA | Kiniksa Pharmaceuticals International, plc | 1.82% |
| 21 | WST | West Pharmaceutical Services, Inc. | 1.79% |
| 22 | EW | Edwards Lifesciences Corporation | 1.68% |
| 23 | VEEV | Veeva Systems Inc. | 1.57% |
| 24 | EBR: UCB | UCB SA | 1.57% |
| 25 | GH | Guardant Health, Inc. | 1.56% |
As of Sep 11, 2026